Avocado has been cultivated in south-central Mexico for thousands of years, with archaeological evidence suggesting use predating 5,000 BCE, making it one of the oldest continuously cultivated fruits in the Americas. Spanish colonizers carried it back to Europe, though avocado's global culinary explosion is a genuinely recent, 21st-century phenomenon.
Avocado's exceptionally high monounsaturated fat content has driven substantial modern research into cardiovascular effects, offering a genuinely instructive example of how a more rigorous synthesis can meaningfully narrow an earlier, broader positive finding.
Avocado's cardiovascular evidence has evolved with more rigorous synthesis over time. An earlier 2016 meta-analysis (10 studies, 229 participants) found avocado-substituted diets significantly reduced total cholesterol, LDL, and triglycerides. However, the American Heart Association's own 2022 review described the broader published literature as "inconclusive," citing "inconsistent effects" across individual trials.
The most recent, most rigorous synthesis — a 2025 GRADE-assessed meta-analysis of 10 RCTs — found no significant effect on triglycerides, total cholesterol, HDL, fasting glucose, BMI, or CRP, but did find a significant reduction in LDL cholesterol and a modest reduction in systolic blood pressure. A large prospective cohort found each half-serving-per-day increase associated with a 20% lower cardiovascular disease hazard ratio. Given the most rigorous recent synthesis narrowing the effect specifically to LDL and blood pressure, "Moderate" is the accurate, appropriately updated rating.
Fruit eaten fresh, mashed, or sliced; used in both savory and, increasingly, sweet culinary applications worldwide.